Characteristics and treatment of human epidermal growth factor receptor 2 positive breast cancer: 43,485 cases from the National Cancer Database treated in 2010 and 2011-Reference-Cited by-同舟云学术

Characteristics and treatment of human epidermal growth factor receptor 2 positive breast cancer: 43,485 cases from the National Cancer Database treated in 2010 and 2011

Published:2017-02 Issue:2 Volume:213 Page:426-432
ISSN:0002-9610
Container-title:The American Journal of Surgery
language:en
Short-container-title:The American Journal of Surgery

Author:

Killelea Brigid K.,Chagpar Anees B.,Horowitz Nina R.,Lannin Donald R.

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference23 articles.

1. HER2 in breast cancer: a review and update;Krishnamurti;Adv Anat Pathol,2014

2. Treatment of HER2-positive breast cancer: current status and future perspectives;Arteaga;Nat Rev Clin Oncol,2012

3. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study;Carey;JAMA,2006

4. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

5. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer;Romond;N Engl J Med,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast cancer molecular subtype and relationship with clinicopathological profiles among Vietnamese women: A retrospective study;Pathology - Research and Practice;2023-10

2. High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer;PLOS ONE;2023-01-27

3. miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy;Breast Cancer: Targets and Therapy;2022-03

4. Trastuzumab deruxtecan in HER2-positive metastatic breast cancer and beyond;Expert Opinion on Biological Therapy;2021-04-01

5. Synopsis of the Treatment of Breast Cancer;The Future of Prevention and Treatment of Breast Cancer;2021